Phase II Clinical Study: A Randomized, Open, and Dose Ranging Study to Evaluate the Efficacy and Safety of DLBS-1425 in Subjects With Metastatic / Advanced (Stage IIIB / IV) Breast Cancer.

Trial Profile

Phase II Clinical Study: A Randomized, Open, and Dose Ranging Study to Evaluate the Efficacy and Safety of DLBS-1425 in Subjects With Metastatic / Advanced (Stage IIIB / IV) Breast Cancer.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 17 Oct 2012

At a glance

  • Drugs Phaleria macrocarpa (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Sep 2011 Planned end date changed from 1 Dec 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
    • 27 Dec 2010 Actual initiation date changed from Apr 2010 to Aug 2009 as reported by ClinicalTrials.gov.
    • 27 Dec 2010 Planned end date changed from 1 Feb 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top